Trial now

Repo Reference Rates


Cable eye MNI tech resistance

Sign up now for free access to this content.

Please enter your details below and select your areas of interest.

The Nikkei 225 tagged fresh multi-decade highs on Tuesday, benefitting from positive reports surrounding the domestic COVID vaccine drive in Japan and expectations surrounding post-election stimulus. Elsewhere, it was China Evergrande that continued to steal the headlines, with the giant property developer flagging further risks and headwinds to company operations, while it confirmed that it has hired restructuring advisors to explore avenues out of its multitude of problems. The CSI 300 and Hang Seng both trade a little below unchanged levels. U.S. e-minis added incrementally to Monday's rally. Participants are zeroed in on Tuesday's U.S. CPI print.